Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tarun Bhargava

Adult Reconstructive Orthopaedic Surgery Wichita, KS Medical Doctor

NPI 1952527442 CMS profile 43644

1923 N Webb Rd, Wichita, KS 67206

Open in the dashboard

General payments

$533,798

408 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$1,361,590

7 holdings reported · through program year 2025

Research they led as principal investigator

$2,885 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Tarun Bhargava of Wichita, KS is reported in the CMS Open Payments database as having received $533,798 across 408 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,885 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $1,361,590 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $44,680 39
2024 General $58,872 44
2023 General $130,652 116
2022 General $64,808 53
2021 General $55,083 53
2020 General $77,390 50
2019 General $102,313 53
2025 Ownership $260,326 1
2024 Ownership $258,179 1
2023 Ownership $218,581 1
2022 Ownership $195,913 1
2021 Ownership $161,860 1
2020 Ownership $140,373 1
2019 Ownership $126,359 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tarun Bhargava
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Tarun Bhargava were reported at $44,680. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Tarun Bhargava Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $102,313 $1,416 $292–$9,336 $163
2020 $77,390 $647 $141–$6,474 $114
2021 $55,083 $1,073 $211–$6,497 $132
2022 $64,808 $1,217 $236–$6,299 $149
2023 $130,652 $1,082 $246–$6,818 $160
2024 $58,872 $1,575 $323–$8,944 $164
2025 $44,680 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Encore Medical, LP $473,887 331 payments
  2. Orthalign Inc $45,193 23 payments
  3. Innovation Technologies Inc $11,452 9 payments
  4. Pacira Pharmaceuticals Incorporated $1,154 6 payments
  5. Stryker Corporation $1,137 9 payments
  6. Conformis, Inc. $223 3 payments
  7. Anika Therapeutics, Inc. $200 3 payments
  8. Medacta USA, Inc. $168 3 payments
  9. Flexion Therapeutics, Inc. $73 5 payments
  10. Avanos Medical $73 2 payments
  11. Other $238 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $306,985 142 payments
  2. Royalty or License $179,366 24 payments
  3. Travel and Lodging $34,320 88 payments
  4. Food and Beverage $7,459 151 payments
  5. Honoraria $4,455 1 payment
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,213 2 payments
Products named General payments · program years 2019–2025
  1. DJO SURGICAL Joint Implants $141,180 97 payments
  2. DJO SURGICAL Joint Implants $92,118 67 payments
  3. DJO Surgical Empowr Knee System Joint Implants $76,561 36 payments
  4. DJO Surgical TaperFill Hip System $35,409 17 payments
  5. DJO Surgical Empowr Knee System Joint Implants $33,123 9 payments
  6. OrthAlign Plus System $32,825 9 payments
  7. DJO SURGICAL Joint Implants $28,117 21 payments
  8. DJO SURGICAL Joint Implants $26,821 37 payments
  9. DJO SURGICAL Joint Implants $21,771 18 payments
  10. DJO SURGICAL Joint Implants $20,176 16 payments
  11. Other $102,104 179 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

652

Median for Orthopedic Surgery: 203

Drug cost

$1,405

Median for Orthopedic Surgery: $1,433

Branded share of claims

2.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 484 $656
Celecoxib Generic 24 $337
Clindamycin Hcl Generic 99 $242
Ondansetron Odt Ondansetron Brand 16 $81
Cyclobenzaprine Hcl Generic 16 $49
Cephalexin Generic 13 $38

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$323,068

Of which drugs: $15,005

Medicare patients

633

Average age 74

Services billed

4,510

412 women, 221 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Diabetes 26%
Ischemic heart disease 26%
Depression 25%
Chronic kidney disease 18%
Atrial fibrillation 17%
COPD 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 32 103 $9,773
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 151 1,848 $1,307

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zilretta
  • Pacira Pharmaceuticals Incorporated $5
$5 — —
Exparel
  • Pacira Pharmaceuticals Incorporated $5
$5 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

408 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record